SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is trending due to new exchange listings, expanded utility like Solana integration, and its AI agent capabilities on the Base ecosystem, driving community speculation for a significant price surge amidst ongoing "pump and dump" concerns.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is trending as a leading privacy solution for Solana, with its recent integration into Solflare and strong ecosystem partnerships fueling community excitement. Investors are bullish on its low market cap, anticipating significant growth and future revenue sharing from its utility-driven platform.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to significant volatility following its decision to discontinue a compounded oral GLP-1 weight-loss pill, which stemmed from increased FDA scrutiny and legal threats from Novo Nordisk. Community discussion is sharply divided between those predicting further declines due to management's perceived missteps and others who see it as a strategic move to remove regulatory overhang, highlighting the company's broader telehealth offerings and potential for a short squeeze.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around the upcoming 4/20 cultural event, emphasizing its mission to support global cannabis legalization and foster a culture of holistic health and environmental consciousness, often proclaiming itself "like Bitcoin but way higher."

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is experiencing significant recent price volatility, prompting intense community debate over whether it represents an oversold opportunity akin to early Robinhood or faces ongoing pressure from dilution and management concerns. Investors are closely monitoring its performance against broader market trends and its perceived correlation with crypto, with many frustrated by its substantial decline.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending following its recent earnings, which highlighted robust user and revenue growth alongside management's commitment to substantial share buybacks; however, community discussion is polarized by concerns over its immediate profitability metrics and the evolving landscape of autonomous vehicle competition.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as regulatory bodies signal swift action against unauthorized compounded GLP-1 weight-loss drugs, prompting widespread community discussion about how this bolsters NVO's market position and intellectual property, potentially mitigating concerns from its recent conservative outlook.

The AES Corp. engages in the provision of power generation and utility services through its renewable and thermal generation facilities and distribution businesses. It operates through the following segments: U.S. and Utilities Strategic Business Unit (SBU), South America SBU, MCAC SBU, Eurasia SBU. The U.S. and Utilities SBU segment consists of facilities in the United States, Puerto Rico and El Salvador. The South America SBU segment covers Chile, Colombia, Argentina, and Brazil. The MCAC SBU segment refers to Mexico, Central America, and the Caribbean. The Eurasia SBU segment handles operations in Europe and Asia. The company was founded by Dennis W. Bakke and Roger W. Sant in 1981 and is headquartered in Arlington, VA.

AES Corp.

AES is actively trending amid speculation that BlackRock's Global Infrastructure Partners is nearing a takeover, with community discussions largely centered on the company's attractive position in supplying energy for the rapidly expanding AI and data center industries, juxtaposed with debates over the appropriate acquisition premium given its substantial debt load.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following strong preliminary Q4 results and robust 2026 revenue guidance for its MS drug Briumvi, fueling community discussions about the stock's perceived undervaluation. Investors are actively debating the potential for a strategic acquisition, driven by Briumvi's growing market share and the anticipated subcutaneous formulation data.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending due to anticipation of accelerated growth in its upcoming Q4 earnings and seasonally strong Q1, coupled with new partnerships like Kikoff and potential deep integration with Hyundai Secure+. The community actively discusses its significant undervaluation, strong AI-driven fundamentals, and high short interest despite recent market pressure, signaling potential for a substantial rebound or even a buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Federated Hermes Inc. Takes Position in Madrigal Pharmaceuticals, Inc. $MDGL

Federated Hermes Inc. bought a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

New York State Common Retirement Fund Grows Position in Madrigal Pharmaceuticals, Inc. $MDGL

New York State Common Retirement Fund increased its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 13.4% in the third quarter, according to the company in its most...

Madrigal Pharmaceuticals, Inc. $MDGL Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. decreased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 28.3% in the 3rd quarter, according to the company in its most recent...

Madrigal Pharmaceuticals (NASDAQ:MDGL) Now Covered by Barclays

Barclays assumed coverage on shares of Madrigal Pharmaceuticals in a research note on Tuesday. They set an "overweight" rating and a $964.00 target price on the stock...

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 647 Shares of Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 647 shares of the business's stock in a transaction that occurred on Monday, January 26th. The stock was sold...

Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Rebecca Taub Sells 647 Shares

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 647 shares of the business's stock in a transaction on Monday, January 26th. The shares were sold at an...

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells 1,577 Shares of Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) CEO William John Sibold sold 1,577 shares of the firm's stock in a transaction on Monday, January 26th. The shares were sold at an...

Carole Huntsman Sells 910 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) insider Carole Huntsman sold 910 shares of the business's stock in a transaction that occurred on Monday, January 26th. The shares were...

STVN or MDGL: Which Is the Better Value Stock Right Now?

STVN vs. MDGL: Which Stock Is the Better Value Option?

Madrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH raised its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 388.3% during the third quarter, according to the company in...

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

MDGL
Madrigal Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MDGL News

MDGLMadrigal Pharmaceuticals Inc